Growth Metrics

Nektar Therapeutics (NKTR) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Nektar Therapeutics (NKTR) over the last 9 years, with Dec 2024 value amounting to $14.5 million.

  • Nektar Therapeutics' Interest & Investment Income fell 17.98% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year decrease of 34.44%. This contributed to the annual value of $14.5 million for FY2024, which is 23.72% down from last year.
  • Per Nektar Therapeutics' latest filing, its Interest & Investment Income stood at $14.5 million for FY2024, which was down 23.72% from $19.0 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Interest & Investment Income high stood at $19.0 million for FY2023, and its period low was $2.7 million during FY2021.
  • For the 3-year period, Nektar Therapeutics' Interest & Investment Income averaged around $13.4 million, with its median value being $14.5 million (2024).
  • As far as peak fluctuations go, Nektar Therapeutics' Interest & Investment Income skyrocketed by 180.24% in 2023, and later dropped by 23.72% in 2024.
  • Nektar Therapeutics' Interest & Investment Income (Yearly) stood at $2.7 million in 2021, then soared by 148.37% to $6.8 million in 2022, then spiked by 180.24% to $19.0 million in 2023, then declined by 23.72% to $14.5 million in 2024.